Sanofi SA (SAN.PA) — Quality & forensics

As of 2026-08-06 — refreshed nightly. Closelook readings from an investment research diary, not ratings or advice.

The Closelook module scores

57 /100 composite · 7 modules · general weight set

Valuation 77
Quality 70
Growth 40
Balance sheet 36
Cash quality 47
Capital allocation 93
Momentum 44

Scores are computed nightly across the coverage universe and read relative to it — the methodology lives in the company-scoring explainer.

Financial forensics — the academic screens

2.37 Altman Z-Score

Sits in the grey zone (1.81–2.99). The Z-Score estimates financial-distress risk from five balance-sheet and earnings ratios.

7/9 Piotroski F-Score

Nine binary fundamental-strength checks across profitability, leverage and operating efficiency.

-2.59 Beneish M-Score

Screens reported earnings for statistical manipulation patterns — below the −1.78 manipulation-risk threshold. A screen, not an accusation.

Continue: the SAN.PA chart & overview

FAQ · from the current data · as of 2026-08-06

Quick answers

What is Sanofi SA's Closelook quality reading?

The composite reads 57/100 across 7 modules, as of 2026-08-06: valuation 77, quality 70, growth 40, balance sheet 36, cash quality 47, capital allocation 93, momentum 44. Closelook scores are research diary readings, not ratings or investment advice.

What is Sanofi SA's Altman Z-Score?

2.37, which sits in the grey zone (1.81–2.99) as of 2026-08-06. The Altman Z-Score estimates financial distress risk from five balance-sheet and earnings ratios.

What is Sanofi SA's Piotroski F-Score?

7 of 9, as of 2026-08-06. The F-Score counts nine binary fundamental-strength signals across profitability, leverage and operating efficiency.

What does Sanofi SA's Beneish M-Score indicate?

-2.59 — below the −1.78 manipulation-risk threshold, as of 2026-08-06. The M-Score screens reported earnings for statistical manipulation patterns; it is a screen, not an accusation.